CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAI Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease Management of No-Reflow Phenomenon in the Catheterization Laboratory Clinical Implications of Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention for Chronic Total Occlusion: Role of Antegrade and Retrograde Crossing Techniques Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design New AHA/ACC/HRS Guidance on Sudden Cardiac Death Prevention

Original ResearchJuly 15, 2021

JOURNAL:PLoS One. Article Link

Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry

LB Daniels, JT Ren, K Kumar et al. Keywords: COVID-19; CVD patients; statin prevention; death

FULL TEXT PDF